Suivre
Dr Lewis Fletcher Buss
Dr Lewis Fletcher Buss
Centre for Academic Primary Care, Univeristy of Bristol
Adresse e-mail validée de bristol.ac.uk
Titre
Citée par
Citée par
Année
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
EC Sabino, LF Buss, MPS Carvalho, CA Prete, MAE Crispim, NA Fraiji, ...
The Lancet 397 (10273), 452-455, 2021
9192021
Evolution and epidemic spread of SARS-CoV-2 in Brazil
DS Candido, IM Claro, JG De Jesus, WM Souza, FRR Moreira, ...
Science 369 (6508), 1255-1260, 2020
6482020
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
LF Buss, CA Prete Jr, CMM Abrahim, A Mendrone Jr, T Salomon, ...
Science 371 (6526), 288-292, 2021
5152021
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
WM de Souza, LF Buss, DS Candido, JP Carrera, S Li, AE Zarebski, ...
Nature human behaviour 4 (8), 856-865, 2020
4342020
Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil
SL Li, RHM Pereira, CA Prete Jr, AE Zarebski, L Emanuel, PJH Alves, ...
BMJ Global Health 6 (4), e004959, 2021
862021
Serial interval distribution of SARS-CoV-2 infection in Brazil
CA Prete Jr, L Buss, A Dighe, VB Porto, D da Silva Candido, F Ghilardi, ...
Journal of travel medicine 28 (2), taaa115, 2021
552021
Brazil-UK Centre for Arbovirus Discovery
DS Candido, IM Claro, JG Jesus, WM Souza, FRR Moreira, S Dellicour, ...
Diagnosis, Genomics and Epidemiology (CADDE) Genomic Network, Ferguson NM …, 2020
502020
COVID-19 herd immunity in the Brazilian Amazon
LF Buss, CA Prete Jr, CMM Abrahim, A Mendrone Jr, T Salomon, ...
medRxiv, 2020.09. 16.20194787, 2020
472020
Intracerebral haemorrhage in Down syndrome: protected or predisposed?
L Buss, E Fisher, J Hardy, D Nizetic, J Groet, L Pulford, A Strydom
F1000Research 5, 2016
432016
Performance of at-home self-collected saliva and nasal-oropharyngeal swabs in the surveillance of COVID-19
PH Braz-Silva, AC Mamana, CM Romano, AC Felix, AV de Paula, ...
Journal of oral microbiology 13 (1), 1858002, 2021
422021
Dataset on SARS-CoV-2 non-pharmaceutical interventions in Brazilian municipalities
AA de Souza Santos, DS Candido, WM de Souza, L Buss, SL Li, ...
Scientific data 8 (1), 73, 2021
392021
Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study
FE Leal, MC Mendes-Correa, LF Buss, SF Costa, JCS Bizario, ...
BMJ open 11 (1), e042745, 2021
372021
Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals
A Brizzi, C Whittaker, LMS Servo, I Hawryluk, CA Prete Jr, WM de Souza, ...
Nature medicine 28 (7), 1476-1485, 2022
342022
Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
CA Prete Jr, LF Buss, R Buccheri, CMM Abrahim, T Salomon, ...
BMC infectious diseases 22 (1), 127, 2022
322022
SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers (HCW): estimating the impact of community transmission
SF Costa, P Giavina-Bianchi, L Buss, CH Mesquita Peres, MM Rafael, ...
Clin Infect Dis 13, 2020
272020
Spatiotemporal dynamics and recurrence of chikungunya virus in Brazil: an epidemiological study
WM de Souza, STS de Lima, LMS Mello, DS Candido, L Buss, ...
The Lancet Microbe 4 (5), e319-e329, 2023
262023
Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi–Seropositive Individuals
MCP Nunes, LF Buss, JLP Silva, LNA Martins, CDL Oliveira, CS Cardoso, ...
Circulation 144 (19), 1553-1566, 2021
252021
Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
TR Tozetto-Mendoza, KA Kanunfre, LS Vilas-Boas, EPS Espinoza, ...
Journal of Virological Methods 290, 114064, 2021
202021
Epidemiology of COVID-19 after emergence of SARS-CoV-2 gamma variant, Brazilian Amazon, 2020–2021
VC Nicolete, PT Rodrigues, ARJ Fernandes, RM Corder, J Tonini, ...
Emerging infectious diseases 28 (3), 709, 2022
192022
Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018
TB Ribeiro, L Buss, C Wayant, MRC Nobre
PLoS One 15 (7), e0236345, 2020
192020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20